Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
551
-
Total 13F shares, excl. options
-
46.7M
-
Shares change
-
+429K
-
Total reported value, excl. options
-
$13.5B
-
Value change
-
+$147M
-
Put/Call ratio
-
1.51
-
Number of buys
-
258
-
Number of sells
-
-255
-
Price
-
$289.83
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2021
624 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2021.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 551 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.7M shares
of 50.5M outstanding shares and own 92.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.59M shares), VANGUARD GROUP INC (5.16M shares), FMR LLC (2.03M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.38M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.26M shares), STATE STREET CORP (1.15M shares), Invesco Ltd. (1.11M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (992K shares), MARSHALL WACE, LLP (917K shares), and AMERIPRISE FINANCIAL INC (909K shares).
This table shows the top 551 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.